CMIC expands China presence through stake in local CRO
This article was originally published in Scrip
Executive Summary
The Japanese contract research organisation CMIC has acquired a 21% stake in a Chinese provider of clinical trial and other services to the pharmaceutical industry in a bid to strengthen its presence in the country.